Journal - Research Article

McDougall, L. I., Powell, R. M., Ratajska, M., Lynch-Sutherland, C. F., Hossain, S. M., Wiggins, G. A. R., … Motwani, J., Reid, G., Walker, L. C., … Eccles, M. R. (2021). Differential expression of BARD1 isoforms in melanoma. Genes, 12(2), 320. doi: 10.3390/genes12020320

Golden, E., Rashwan, R., Woodward, E. A., Sgro, A., Wang, E., Sorolla, A., … Ratajska, M., … Blancafort, P. (2021). The oncogene AAMDC links P13K-AKT-mTOR signaling with metabolic reprograming in estrogen receptor-positive breast cancer. Nature Communications, 12, 1920. doi: 10.1038/s41467-021-22101-7

Suszynska, M., Ratajska, M., & Kozlowski, P. (2020). BRIP1, RAD51C, and RAD51D mutations are associated with high susceptibility to ovarian cancer: Mutation prevalence and precise risk estimates based on a pooled analysis of ~30,000 cases. Journal of Ovarian Research, 13(1), 50. doi: 10.1186/s13048-020-00654-3

Wiczling, P., Daghir-Wojtkowiak, E., Kaliszan, R., Markuszewski, M. J., Limon, J., Koczkowska, M., … Ratajska, M. (2019). Bayesian multilevel model of micro RNA levels in ovarian-cancer and healthy subjects. PLoS ONE, 14(8), e0221764. doi: 10.1371/journal.pone.0221764

Suszynska, M., Kluzniak, W., Wokolorczyk, D., Jakubowska, A., Huzarski, T., Gronwald, J., … Ratajska, M., … Kozlowski, P. (2019). BARD1 is a low/moderate breast cancer risk gene: Evidence based on an association study of the Central European p.Q564x recurrent mutation. Cancers, 11(6), 740. doi: 10.3390/cancers11060740

Koczkowska, M., Krawczynska, N., Stukan, M., Kuzniacka, A., Brozek, I., Sniadecki, M., … Ratajska, M. (2018). Spectrum and prevalence of pathogenic variants in ovarian cancer susceptibility genes in a group of 333 patients. Cancers, 10(11), 442. doi: 10.3390/cancers10110442

Klonowska, K., Kluzniak, W., Rusak, B., Jakubowska, A., Ratajska, M., Krawczynska, N., … Kozlowski, P. (2017). The 30 kb deletion in the APOBEC3 cluster decreases APOBEC3A and APOBEC3B expression and creates a transcriptionally active hybrid gene but does not associate with breast cancer in the European population. Oncotarget, 8(44), 76357-76374. doi: 10.18632/oncotarget.19400

Ratajska, M., Koczkowska, M., Żuk, M., Gorczyński, A., Kuźniacka, A., Stukan, M., … Wasąg, B. (2017). Detection of BRCA1/2 mutations in circulating tumor DNA from patients with ovarian cancer. Oncotarget, 8(60), 101325-101332. doi: 10.18632/oncotarget.20722

Pilyugin, M., André, P.-A., Ratajska, M., Kuzniacka, A., Limon, J., Tournier, B. B., … Irminger-Finger, I. (2017). Antagonizing functions of BARD1 and its alternatively spliced variant BARD1δ in telomere stability. Oncotarget, 8(6), 9339-9353. doi: 10.18632/oncotarget.14068

Szutowicz-Kielińska, E., Konopa, K., Kowalczyk, A., Suszko-Każarnowicz, M., Duchnowska, R., Szczęsna, A., Ratajska, M., … Dziadziuszko, R. (2017). An open label phase II study evaluating first-line EGFR tyrosine kinase inhibitor erlotinib in non-small cell lung cancer patients with tumors showing high EGFR gene copy number. Oncotarget, 8(10), 17270-17278. doi: 10.18632/oncotarget.13793

Koczkowska, M., Zuk, M., Gorczynski, A., Ratajska, M., Lewandowska, M., Biernat, W., … Wasag, B. (2016). Detection of somatic BRCA1/2 mutations in ovarian cancer: Next-generation sequencing analysis of 100 cases. Cancer Medicine, 5(7), 1640-1646. doi: 10.1002/cam4.748

Ratajska, M., Matusiak, M., Kuzniacka, A., Wasag, B., Brozek, I., Biernat, W., … Irminger-Finger, I. (2015). Cancer predisposing BARD1 mutations affect exon skipping and are associated with overexpression of specific BARD1 isoforms. Oncology Reports, 34(5), 2609-2617. doi: 10.3892/or.2015.4235

Klonowska, K., Ratajska, M., Czubak, K., Kuzniacka, A., Brozek, I., Koczkowska, M., … Kozlowski, P. (2015). Analysis of large mutations in BARD1 in patients with breast and/or ovarian cancer: The Polish population as an example. Scientific Reports, 5, 10424. doi: 10.1038/srep10424

Ronowicz, A., Janaszak-Jasiecka, A., Skokowski, J., Madanecki, P., Bartoszewski, R., Bałut, M., … Ratajska, M., … Piotrowski, A. (2015). Concurrent DNA copy-number alterations and mutations in genes related to maintenance of genome stability in uninvolved mammary glandular tissue from breast cancer patients. Human Mutation, 36(11), 1088-1099. doi: 10.1002/humu.22845

Kreimann, E. L., Ratajska, M., Kuzniacka, A., Demacopulo, B., Stukan, M., & Limon, J. (2015). A novel splicing mutation in the SLC9A3R1 gene in tumors from ovarian cancer patients. Oncology Letters, 10(6), 3722-3726. doi: 10.3892/ol.2015.3796

Ratajska, M., Krygier, M., Stukan, M., Kuźniacka, A., Koczkowska, M., Dudziak, M., … Wasąg, B. (2015). Mutational analysis of BRCA1/2 in a group of 134 consecutive ovarian cancer patients. Novel and recurrent BRCA1/2 alterations detected by next generation sequencing. Journal of Applied Genetics, 56(2), 193-198. doi: 10.1007/s13353-014-0254-5

Kuzniacka, A., Wierzba, J., Ratajska, M., Lipska, B. S., Koczkowska, M., Malinowska, M., & Limon, J. (2013). Spectrum of NIPBL gene mutations in Polish patients with Cornelia de Lange syndrome. Journal of Applied Genetics, 54(1), 27-33. doi: 10.1007/s13353-012-0126-9

Brozek, I., Ratajska, M., Piatkowska, M., Kluska, A., Balabas, A., Dabrowska, M., … Limon, J. (2012). Limited significance of family history for presence of BRCA1 gene mutation in Polish breast and ovarian cancer cases. Familial Cancer, 11(3), 351-354. doi: 10.1007/s10689-012-9519-5

Ratajska, M., Antoszewska, E., Piskorz, A., Brozek, I., Borg, Å., Kusmierek, H., … Limon, J. (2012). Cancer predisposing BARD1 mutations in breast-ovarian cancer families. Breast Cancer Research & Treatment, 131(1), 89-97. doi: 10.1007/s10549-011-1403-8

Brozek, I., Cybulska, C., Ratajska, M., Piatkowska, M., Kluska, A., Balabas, A., … Limon, J. (2011). Prevalence of the most frequent BRCA1 mutations in Polish population. Journal of Applied Genetics, 52(3), 325-330. doi: 10.1007/s13353-011-0040-6

Ratajska, M., Wierzba, J., Pehlivan, D., Xia, Z., Brundage, E. K., Cheung, S. W., … Limon, J. (2010). Cornelia de Lange syndrome case due to genomic rearrangements including NIPBL. European Journal of Medical Genetics, 53(6), 378-382. doi: 10.1016/j.ejmg.2010.08.002

Niedoszytko, M., Ratajska, M., Chelmińska, M., Makowiecki, M., Malek, E., Siemińska, A., … Jassem, E. (2010). The angiotensinogen AGT p.M235T gene polymorphism may be responsible for the development of severe anaphylactic reactions to insect venom allergens. International Archives of Allergy & Immunology, 153(2), 166-172. doi: 10.1159/000312634

Brożek, I., Ochman, K., Dębniak, J., Morzuch, L., Ratajska, M., Stepnowska, M., … Limon, J. (2009). Loss of heterozygosity at BRCA1/2 loci in hereditary and sporadic ovarian cancers. Journal of Applied Genetics, 50(4), 379-384. doi: 10.1007/BF03195697

Ratajska, M., Brozek, I., Senkus-Konefka, E., Jassem, J., Stepnowska, M., Palomba, G., … Limon, J. (2008). BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland. Oncology Reports, 19(1), 263-268. doi: 10.3892/or.19.1.263

Brozek, I., Ochman, K., Debnik, J., Morzuch, L., Ratajska, M., Stepnowska, M., … Limon, J. (2008). High frequency of BRCA1/2 germline mutations in consecutive ovarian cancer patients in Poland. Gynecologic Oncology, 108(2), 433-437. doi: 10.1016/j.ygyno.2007.09.035

Brożek, I., Kardaś, I., Ochman, K., Dębniak, J., Stukan, M., Ratajska, M., … Limon, J. (2006). HER2 amplification has no prognostic value in sporadic and hereditary ovarian tumours. Hereditary Cancer in Clinical Practice, 4(1), 39-42. doi: 10.1186/1897-4287-4-1-39

Majdak, E. J., De Bock, G. H., Brozek, I., Perkowska, M., Ochman, K., Debniak, J., … Devilee, P. (2005). Prevalence and clinical correlations of BRCA1/BRCA2 unclassified variant carriers among unselected primary ovarian cancer cases: Preliminary report. European Journal of Cancer, 41(1), 143-150. doi: 10.1016/j.ejca.2004.10.011

Menkiszak, J., Gronwald, J., Górski, B., Jakubowska, A., Huzarski, T., Byrski, T., … Perkowska, M., … Lubiński, J. (2003). Hereditary ovarian cancer in Poland. International Journal of Cancer, 106(6), 942-945. doi: 10.1002/ijc.11338

Perkowska, M., Szczygieł, M., & Woźniak, A. (2001). Influence of diethylenetriamine (DETA) and sodium nitroprusside (NaNP) on sister chromatid exchange frequency and cell kinetics in cultured human lymphocytes. Journal of Applied Genetics, 42(2), 233-235.

^ Top of page

Journal - Research Other

Irminger-Finger, I., Ratajska, M., & Pilyugin, M. (2016). New concepts on BARD1: Regulator of BRCA pathways and beyond. International Journal of Biochemistry & Cell Biology, 72, 1-17. doi: 10.1016/j.biocel.2015.12.008

Bogdanova, N., Togo, A. V., Ratajska, M., Kluźniak, W., Takhirova, Z., Tarp, T., … Dörk, T. (2015). Prevalence of the BLM nonsense mutation, p.Q548X, in ovarian cancer patients from Central and Eastern Europe [Short communication]. Familial Cancer, 14(1), 145-149. doi: 10.1007/s10689-014-9748-x

Wierzba, J., Kuzniacka, A., Ratajska, M., Lipska, B. S., Kardas, I., Iliszko, M., & Limon, J. (2011). Cornelia de Lange syndrome associated with a de-novo novel NIPBL splice-site mutation and a coincidental inherited translocation t(3;5)(p13;q11). Clinical Dysmorphology, 20(4), 222-224. doi: 10.1097/MCD.0b013e3283455175

Perkowska, M., Brozek, I., Wysocka, B., Haraldsson, K., Sandberg, T., Johansson, U., … Limon, J. (2003). BRCA1 and BRCA2 mutation analysis in breast-ovarian cancer families from northeastern Poland. Human Mutation, 21(5), 553-554. doi: 10.1002/humu.9139